BIOLINK GROUP AS

4323 SANDNES

Finances

Return on Equity

−23,11 %

Current Ratio

7,02

Debt-to-Equity Ratio

0,52

Key figures (NOK)	2022	2021	2020	2019
Revenue	5 017 000	5 630 000	5 538 000	5 701 000
Net Income	−12 209 000	−13 641 000	−11 771 000	−9 051 000
Total Assets	83 856 000	99 026 000	112 767 000	114 806 000
Total Equity	52 841 000	65 050 000	78 692 000	90 264 000

Income (NOK)	2022	2021	2020	2019
Revenue	5 017 000	5 630 000	5 538 000	5 701 000
Expenditure	16 124 000	19 312 000	18 198 000	16 858 000
Operating Profit	−11 144 000	−13 671 000	−12 646 000	−11 193 000
Financial Income	383 000	294 000	618 000	1 321 000
Financial Costs	1 232 000	652 000	216 000	0
Financial Balance	−849 000	−358 000	402 000	1 321 000
Earnings Before Tax	−11 993 000	−14 029 000	−12 245 000	−9 872 000
Tax	216 000	−388 000	−474 000	−822 000
Net Income	−12 209 000	−13 641 000	−11 771 000	−9 051 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	58 216 000	57 388 000	58 132 000	37 408 000
Total Current Assets	25 639 000	41 638 000	54 635 000	77 398 000
Total Assets	83 856 000	99 026 000	112 767 000	114 806 000
Total Retained Equity	20 395 000	32 604 000	46 248 000	57 834 000
Total Equity	52 841 000	65 050 000	78 692 000	90 264 000
Total Long-Term Debt	27 365 000	28 200 000	29 400 000	19 156 000
Total Current Debt	3 650 000	5 776 000	4 676 000	5 385 000
Total Equity and Debt	83 856 000	99 026 000	112 767 000	114 806 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	5 017 000	5 630 000	5 538 000	5 701 000
Other Income	0	0	0	0
Revenue	5 017 000	5 630 000	5 538 000	5 701 000
Cost of Goods Sold	300 000	325 000	158 000	60 000
Salary Costs	15 192 000	16 018 000	15 135 000	15 371 000
Depreciation	1 356 000	1 409 000	628 000	207 000
Impairment	0	0	0	0
Expenditure	16 124 000	19 312 000	18 198 000	16 858 000
Operating Profit	−11 144 000	−13 671 000	−12 646 000	−11 193 000
Financial Income	383 000	294 000	618 000	1 321 000
Financial Costs	1 232 000	652 000	216 000	0
Financial Balance	−849 000	−358 000	402 000	1 321 000
Dividends	0	0	0	0
Net Income	−12 209 000	−13 641 000	−11 771 000	−9 051 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	7 204 000	5 188 000	4 800 000	4 326 000
Real Eastate	50 035 000	52 200 000	51 909 000	32 725 000
Machinery and Plant Facilities	63 000	0	74 000	111 000
Fixtures	915 000	0	1 350 000	245 000
Total Tangible Assets	51 012 000	52 200 000	53 332 000	33 082 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	58 216 000	57 388 000	58 132 000	37 408 000
Stock	852 000	890 000	879 000	865 000
Total Investments	0	0	0	0
Cash, Bank	21 176 000	37 119 000	50 143 000	72 482 000
Total Current Assets	25 639 000	41 638 000	54 635 000	77 398 000
Total Assets	83 856 000	99 026 000	112 767 000	114 806 000
Total Equity	52 841 000	65 050 000	78 692 000	90 264 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	27 365 000	28 200 000	29 400 000	19 156 000
Creditors	406 000	1 393 000	1 096 000	2 144 000
Unpaid Taxes	1 661 000	1 870 000	2 032 000	1 717 000
Dividends	0	0	0	0
Other Current Debt	1 582 000	2 512 000	1 547 000	1 524 000
Total Current Debt	3 650 000	5 776 000	4 676 000	5 385 000
Total Equity and Debt	83 856 000	99 026 000	112 767 000	114 806 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−23,11 %	−20,97 %	−14,96 %	−10,03 %
Debt-to-Equity Ratio	0,52	0,43	0,37	0,21
Operating Profit Margin	−222,12 %	−242,82 %	−228,35 %	−196,33 %
Current Ratio	7,02	7,21	11,68	14,37
Quick Ratio	9,16	8,52	14,39	17,12
Equity Ratio	0,63	0,66	0,7	0,79
Gross Profit Margin	94,02 %	94,23 %	97,15 %	98,95 %